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Acinetobacter baumannii is a nonfermentative Gram-negative
bacterium commonly found in water and soil.1 Over the last decade
it has become a serious emerging community and nosocomial
pathogen worldwide, known to be responsible for life-threatening
infections.2 Carbapenems are the most commonly used antibiotics
for treating infections caused by A. baumannii, but an increase in
carbapenem-resistant strains of A. baumannii has been reported
worldwide over the last decade,3 mainly through the production of
metallo-beta-lactamases (MBLs) or oxacillinases (carbapenem-
hydrolyzing class D beta-lactamases (CHDLs)).4 Four majorFigure 1. Emergence of carbapenemase-prod
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bacterium, including OXA-23, OXA-40, OXA-58, and OXA-143
beta-lactamase groups, together with the naturally occurring OXA-
51 beta-lactamase.5 Although carbapenemase-producing A. bau-
mannii has been reported in many countries worldwide in Europe,
South America, North America, Australia, and Asia, there are only a
few reports from Africa (Tunisia, Algeria, Egypt, Libya, South Africa,
and Senegal)3,6 (Figure 1).
Here we report the presence of carbapenemase-encoding genes
in imipenem-resistant A. baumannii among multidrug-resistant
clinical isolates collected from the University College Hospital,
Ibadan, south-western Nigeria. Three out of ﬁve (60.0%) A.
baumannii clinical isolates identiﬁed between March and Mayucing Acinetobacter baumannii in Africa.
ternational Society for Infectious Diseases.
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ﬂight mass spectrometry (MALDI-TOF) and partial sequencing of
the rpoB gene, as previously described,7 were multidrug-resistant,
including resistance to imipenem; they were only susceptible to
colistin. A modiﬁed Hodge test (MHT) using MacConkey agar and
an imipenem–ethylenediaminetetraacetic acid (EDTA) combined
disk diffusion test (CDDT) were performed on the carbapenem-
resistant isolates and results showed that all three imipenem-
resistant A. baumannii were positive for carbapenemase.
Real-time polymerase chain reaction (PCR) and standard PCR
for the detection of blaOXA-23, blaOXA-24, blaOXA-58, blaNDM-1, blaIMP,
and blaVIM genes revealed that the three isolates harbored the
blaOXA-23 gene, while none of the strains harbored blaOXA-24, blaOXA-
58, blaNDM-1, blaIMP, or blaVIM genes.
In conclusion, we reemphasize the worrying recent emer-
gence and spread of carbapenemases in clinical isolates of A.
baumannii from Africa (Figure 1). This will certainly lead
clinicians to use colistin as a last resort and lead to the
emergence of pandrug-resistant A. baumannii, as recently
demonstrated in Spain8 and in France.9 Because infections due
to such bacteria are associated with an increased length of stay in
intensive care units and increased mortality, a surveillance
program in Nigerian hospitals is necessary in order to implement
rapid health control policies.
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